Marco Donia

60PUBLICATIONS
186CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (60)

|Sep 17, 2026
Crosstalk between S-nitrosylation and glycation defines a metabolic vulnerability in liver and renal cancers.

|Aug 31, 2026
Five-year survival impact of adjuvant anti-PD-1 therapy in a nationwide cohort of stage III melanoma.

|Aug 20, 2026
Immune-cytokine signature predicts survival in patients with advanced melanoma treated with oncolytic adenovirus TILT-123 and chemotherapy and IL-2-free adoptive TIL therapy.

|Jun 25, 2026
Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma.

|Jun 17, 2026
Quantifying the efficacy-effectiveness gap in first line treatment of metastatic melanoma.

|May 18, 2026
Phenotypic and Functional Characteristics of CD8+ T Cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced Melanoma.

Pageof 10

Frequent Collaborators

27 joint publications

Inge Marie Svane

12 joint publications

Eva Ellebaek

10 joint publications

Troels Holz Borch

8 joint publications

Arianna Draghi